Full and Partial Agonism of a Designed Enzyme Switch

S Jimmy Budiardjo1, Timothy J Licknack1, Michael B Cory1

  • 1Center for Computational Biology, ‡Department of Molecular Biosciences, §High Throughput Screening Laboratory, ∥Protein Structure Laboratory, ⊥Molecular Structures Group The University of Kansas , 2030 Becker Drive, Lawrence, Kansas 66045-7534, United States.

Summary

Researchers engineered protein switches by creating cavities and rescuing activity with ligands. They found optimal function requires a ligand that perfectly matches the cavity, enabling tunable protein control for future applications.

Related Concept Videos

Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.5K
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
64.3K
Allosteric Regulation01:08

Allosteric Regulation

16.1K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.3K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.8K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

3.2K